1. Arbogast JD, Blessed WB, Lacoste H, Gross WS, Gonda RL Jr, Welch RA. Use of two Greenfield caval filters to prevent recurrent pulmonary embolism in a heparin-allergic gravida. Obstet Gynecol 1994;84:652-654
  2. Atrash HK, Rowley D, Hogue C JR. Maternal and perinatal mortality. Curt Opin Obstet Gynecol 1992;4:61-71
  3. Barbour LA, Pickard J. Controversies in thromboembolic disease during pregnancy: a critical review. Obstet Gynecol 1995;86:621-63
  4. Basu D, Gallus A, Hirsh J, Cade J. A prospective study of the value of monitoring heparin treatment with activated partial thromboplastin time. N Engl J Med 1972;287:324327
  5. Baumgartner J, Rachlin J, Beckstead J, et al. Primary central nervous system lymphomas: natural history and response to radiation ,therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurgery 990; 73:206-211.
  6. Bentley PG, Kakkar VV, Scully MF, MacGregor IR, Webb P, Chan P, et al. An objective study of alternative methods of heparin administration. Thromb Res 1980;18:177-187
  7. Berge LN, Lyngmo V, Svensson B, Nordoy A. The bleeding time in women: an influence of sex hormones? Acta Obstet Gynecol Scand 1993;72:423-427
  8. Bermudez M, Grant K, Rodvien R, et al. Non-Hodgkin's lymphoma in a population with or at risk for acquired immunodeficiency syndrome: indications for intensive chemotherapy. Am J Med 1989; 86:71-76.
  9. Berry AJ, Rinaldi MG, Graybill JR. Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS. Antimicrob Agents Chemother 1992; 36:690692.
  10. Blanche S, Rouzioux C, Moscato MCG, et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type I. N Engl J Med 1989;320:1643-1648.
  11. Bloomfield DK. Fetal deaths and malformations associated with the use of coumarin derivatives in pregnancy. Am J Obstet Gynecol 1970; 107:883-888
  12. Bonnar J. Venous thromboembolism and pregnancy. Clin Obstet Gynecol 1981;8:455-473
  13. Boyer PJ, Dillon M, Navaie M, Deveikis A, Keller M, O'Rourke S, Bryson YJ. Factors predictive of maternal-fetal Transmission of HIV-I: Preliminary analysis of Zidovudine given during pregnancy and/or delivery. JAMA 1994;271:1925-30.
  14. Bozzette SA, Larsen RA, Chiu J, et al. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324:580-584.
  15. Bronnimann DA, Adam RD, Galgiani JN, et al. Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med 1987; 106:372-379.
  16. Carpenter CC, Mayer KH, Stein MD, et al. Human immunodeficiency virus infection in North American women: experience with 200 cases and a review of the literature. Medicine 1991;70:307-25.
  17. Chang y, Cesarman E, Pes$in MS, Lee F, Culpepper J, Kaowles DM, and Moore PS. Identification of herpes-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-69, 1994.
  18. Chong BH. Heparin-induced thrombocytopenia. Br J Haematol 1995;89:431-439
  19. Cohen MB, Pernoll ML, Gevirtz CM, Kerstein MD. Septic pelvic thrombophlebitis: an update. Obstet Gynecol 1983; 62:83-8
  20. Connor EM, Sperling Rs, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with Zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173-80.
  21. Connors JM, Klimo P. MACOP-B chemotherapy for malignant lymphomas and related conditions: 1987 update and additional observations. Semin Hematol 1988; 25 [Suppl 2]:41-46.
  22. Coon WW. The spectrum of pulmonary embolism. Twenty years later. Arch Surg 1976;111:398-402
  23. Cranley JJ, Canos AJ, Sull WJ. The diagnosis of deep venous thrombosis. Fallibility of clinical symptoms and signs. Arch Surg 1976; 111:34-36
  24. Dahlman TC, Hellgren MSE, Blomback M. Thrombosis prophylaxis in pregnancy with use of subcutaneous heparin adjusted by monitoring heparin concentrations in plasma. Am J Obstet Gynecol 1989;161:420-425
  25. Dahlman T, Lindvall N, Hellgren M. Osteopeoia in pregnancy during long-term heparin treatment: a radiologic study post parturn. Br J Obstet Gynaecol 1990;97:221-228
  26. De Swiet M, Ward PD, Fidler J, Hotsman A, Katz D, Letsky E, et al. Prolonged heparin therapy in pregnancy causes bone demineralization. Br J Obstet Gynaecol 1983;90:11291134
  27. Delclos GL, Davila F. Thrombolytic therapy for pulmonary embolism in pregnancy: a case report. Am J Obstet Gynecol 1986;155:375-376
  28. Denning DW, Tucker RM, Hanson LH, Stevens DA. Treatment of invasive aspergillosis with itraconazole. Am J Med 1989; 86:791-800.
  29. Denning DW, Tucker RM, Hanson LH, Hamilton JR, Stevens DA. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 1989; 149:2301-2308.
  30. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324:654-662.
  31. Des Jarlais DC, Stoneburner R, Thomas P. Declines in proportion of Kaposi's sarcoma among cases of AIDS in multiple risk groups in New York City. Lancet 2:1024-1025, 1987.
  32. Duff P, Gibbs RS. Pelvic vein thrombophlebitis: diagnostic dilemma and therapeutic challenge. Obstet Gynecol Surv 1983;38:365-373
  33. Dugan M, Subar M, Odajnyk C, et al. Intensive multiagent chemotherapy for AIDS-related diffuse large cell lymphoma (LCL). ASH, San Francisco 1986 Abst 374:124a.
  34. Duliege AM, Amos CI, Felton S, Biggar RJ, Goedert JJ. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins.
  35. Ehrnst A, Lindgren S, Dictor M, Johansson B, Sonnetborg A, Czajkowski J, Sundin G, Bohlin AB. HIV in pregnant women and their offspring: evidence for late transmission. Lancet 1991;338:203-7.
  36. Ensoli B, Nakamura S, Salahuddin SZ, et al. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth factors. Science 243:223-226, 1989.
  37. Ensoli B, Barillari G, and Gallo RC. Pathogenesis of AIDS-associated Kaposi's sarcoma. Hem/Onc Clin No Am 5:281-295, 1991.
  38. Errante D, Tirelli U, Olesenhelder E, et al. Prospective study with combined low dose chemotherapy and zidovudine for 37 patients with poor prognosis HIV-related non-Hodgkin's lymphoma. Proc Am Soc Clin Oncol 1992; Abst 3:44.
  39. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339:1007-12.
  40. Evans GL, Dalen JE, Dexter L. Pulmonary embolism during pregnancy. JAMA 1968;206:320-326
  41. Fessel WJ, Merrill KW, Ward D, et al. Itraconazole oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in HIV-positive patients [Abstr. No. 327]. In: Program and Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, D.C.: Foundation for Retrovirology and Human Health, 2006; pg. 124.
  42. Fichtenbaum C, Koletar S, Yiannoutsos C, et al. Predictors of fluconazole resistant Candida in advanced HIV infection [Abstr. No. I101] . In: Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C.: American Society for Microbiology, 1995; pg. 223.
  43. Formenti SC, Gill PS, Lean E, et al. Primary central nervous system lymphoma in AIDS: results of radiation therapy. Cancer 1989; 63:1 it, i-1107.
  44. Friedman SL. Gastrointestinal and hepatobiliary neoplasms in AIDS. Gastroentol Clin North Am 1988; 17:465-486.
  45. Gill P, Levine A, Krailo M, et al. AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol 1987; 5:1322-1328.
  46. Gill PS, Rarick MU, Espina B, Loureiro C, Berstein-Singer M, Akil B and Levine AM. Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma: results of pilot studies using combination chemotherapy. Cancer 65:1074-1078, 1990.
  47. Gill PS, Tulpule A, Reynolds T, Hadjenberg J, Mocharnuk K, Espina BM, Bresnahan J, Cabriales S, Ilaw M, Shea K, Scadden DT. Paclitaxel (Taxol) in the treatment of relapsed or refractory advanced AIDS-related Kaposi's sarcoma. Am Soc Clin One, 32nd Annual Meeting, Philadelphia PA, August 1821, 2006. Abstract 854, pg. 306.
  48. Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM. Phase VII clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol 1995; 13:996-1003.
  49. Ginsberg JS, Hirsh J, Rainbow AJ, Coates G. Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease. Thromb Haemost 1989;61:189-196
  50. Gisselbrecht C, Oksenhendler E, Tirelli U, et al. HIV-related lymphoma treatment with intensive chemotherapy. Am J Med I993; 95:I88-196.
  51. Graybill JR, Stevens DA, Galgiani JN, Dismukes WE, Cloud GA, and the NIAID Mycoses Study Group. Itraconazole treatment of coccidioidomycosis. Am J Med 1990; 89:282-290.
  52. Greer IA, Barry J, Mackon N, Allan PL. Diagnosis of deep venous thrombosis in pregnancy: a new role for diagnostic ultrasound. Br J Obstet Gynaecol 1990;97:53-57
  53. Griffith GC, Nichols G Jr, Asher JD, Flanagan B. Heparin osteoporosis. JAMA 1965; 193:85-88
  54. Groopman JE, Feder D. Hematopoietic growth factors in AIDS. Seminars in Oncology 19(4):408-414, 1992.
  55. Grutzmeier S, Gerstoft J, Boje HP, et al. Filgrastim use is associated with prolonged survival in AIDS patients with leukopenia and CD4 cells <50 x 106/L. Presented at the 11th International Conference on AIDS, July 7-12, 2006.
  56. Gwinn M, Pappaioanou M, George JR, Harmon WH, Wasser SC, Redus MA, Hoff R, Grady GF, Willoughby A, Novello AC, et al. Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples. JAMA 1991;265:1704-8.
  57. Haeger K. Problems of acute deep venous thrombosis. Angiology 1969;20:219-223
  58. Harbol AW, Liesveld JL, Simpson-Haidaris PJ, et al. Mechanisms of cytopenia in HIV infection. Blood Rev 8:241-251, 1994.
  59. Harrison M. Tomlinson D, Stewart S. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma. J Clin Oncol :995; 13:914-920.
  60. Heijboer H, Biiller HR, Lensing AWA, Tunpie AGG, Colly LP, Wouter ten Cate J. A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic out-patients. N Engl J Med 1993;329:1365-1369
  61. Hengge UR, Brockmeyer NH, Goos M. Granulocyte colony-stimulating factor treatment in AIDS patients. Clinical Investigator 70(10):922-926, 1992.
  62. Hill DR. The role of radiotherapy for epidemic Kaposi's sarcoma. Semin Oncol 14(Suppl 3): 1207-7, 1987.
  63. Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992;79:1-17
  64. Hirsh J. Oral anticoagulant drugs. N Engl J Med 1991; 324: 1865-1875
  65. Hirsh J. Blood tests for the diagnosis of venous and arterial thrombosis. Blood 1981;57:1-8
  66. HIV infection, pregnant women, and newborns. A policy proposal for information and testing. Working Group on HIV Testing of Pregnant Women and Newborns. JAMA 1990;264:2416-20.
  67. Hoff R, Berardi VP, Weiblen BJ, Mahoney-Trout L, Mitchell ML, Grady GF. Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns. N Engl J Med 1988;318:525-30.
  68. Huisman MV, Bullet HR, Cate JWT, Vreeken J. Serial impedance plethysmography for suspected deep vein thrombosis in outpatients. N Engl J Med 1986;314:823-848
  69. Hull RD, Raskob GE, Rosenbloom D, Panju AA, Brill-Edwards P, Ginsberg JS, et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990;322:1260-1264
  70. Hull R, Delmore T, Carter C, Hirsh J, Genton E, Gent M, et al. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med 1982;306:189-194
  71. Hux CH, Wapner RJ, Chayen B, Rattan P, Jarrell B, Greenfield L. Use of the Greenfield filter for thromboembolic disease in pregnancy. Am J Obstet Gynecol 1986; 155:734737
  72. Iman N, Carpenter CCJ, Mayer KH, et al. Hierarchical pattern of mucosal candida infections in HIV-seropositive women. Am J Med 1990; 89:142-146.
  73. Italian Cooperative Group for AIDS-related Tumors. Malignant lymphomas in patients with or at risk for AIDS in Italy: reports. J Nat Can Inst 1988; 80:855-860.
  74. Jacobson MA, Kramer F, Bassiakes Y, et al. Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with CMV retinitis: ACTG 151. J Infect Dis 170:189-193, 1994.
  75. Kaplan LD, Abrams D, Volberding P. Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen. Cancer Treat Rep 70:1121-1122, 1986.
  76. Kaplan L, Abrams DI, Feigal E, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989; 261:719-724.
  77. Kaplan LD, Kahn JO, Crowe S, et al. Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in' patients receiving chemotherapy for human immunodefieiency m-associated non-Hodgkin's lymphora: results of a randomized trial. J Clin Oncol 1991; 9:929-940.
  78. Keiser P, Rademacher S. G-CSF use is associated with decreased bacteremia and increased survival in neutropenic HIV-infected patients (abstract 191). Presented at the 3rd Conference on Retroviruses and Opportunistic Infections, Washington, D.C., Jan. 28-Feb. 1, 2006
  79. Kempczinski RF. Surgical prophylaxis of pulmonary embolism. Chest 1986;89:384s-388s
  80. Khamashta MA, Cuadrado M J, Mujic F, Taub NA, Hunt B J, Hughes GRV. The management of thrombosis in the anti-phospholipid-antibody syndrome. N Engl J Med 1995 ;322: 993-997
  81. Knowles DM, Chamulak G, Subar M, et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 108:744-753.
  82. Koch-Weser J, Sellers EM. Drug interactions with coumarin anticoagulants. N Engl J Med 1971 ;285:547-558
  83. Koonin LM, Ellerbrock TV, Atrash HK, et al. Pregnancy-associated deaths due to AIDS in the United States. JAMA 1989;261:1306-1309.
  84. Kramer WB, Belfort M, Saade GR, Surani S, Moise KJ Jr. Successful urokinase treatment of massive pulmonary embolism in pregnancy. Obstet Gynecol 1995;86:660-662
  85. Krown SE. The role of interferon in the therapy of epidemic Kaposi's sarcoma. Semin Oncol 14(Suppl 3): 27-33, 1987.
  86. Krown SE, Gold JWM, Niedzwiecki D, et al. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Meal 112:812-821, 199.0.
  87. Laine L, Dretler RH, Conteas CN, et al. Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial. Ann Intern Med 1992; 117:655-660.
  88. Lake-Bakaar G, Tom W, Lake-Bakaar D, et al. Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 109:471-473.
  89. Landesman SH, Kalish LA, Burns DA, Minkoff H, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. N Engl J Med 2006;334:1617-23.
  90. Landesman S, Minkoff H, Holman S, et al. Serosurvey of human immunodeficiency virus infection in parturients. JAMA 1987;258:2701-2703.
  91. Ledger W J, Peterson EP. The use of heparin in the management of pelvic thrombophlebitis. Surg Gynecol Obstet 1970; 131:1115-1121
  92. Lensing AWA, Prandoni P, Brandjes D, Huisman PM, Vigo M, Tomasella G, et al. Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 1989; 320:342-345
  93. Levine JD, Allan JD, Tessitore JH, et al. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex. Blood 78:3148-3154, 1991.
  94. Levine AM, Sullivan-Halley J, Pike MC, et al. Human immunodeficiency virus-related lymphoma: prognostic factors predictive of survival. Cancer 1991; 68:2466-2472.
  95. Levine AM, Wemz JC, Kaplan L, et al. Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma: a prospective multi-institutional trial. JAMA 1991; 266:84-88.
  96. Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992; 80:8-20.
  97. Lowenthal DA, Straus D J, Campbell SW, et al. AiDS-related lymphoid neoplasia: the Memorial Hospital experience. Cancer 1988; 61:2325-2337.
  98. Marion RW, Wiznia AA, Hutcheon G, et al. Human T-cell lymphotropic virus type III (HTLV-III) embryopathy. AJDC 1986;140:638-40.
  99. Milefchik E, Leal M, Haubrich R, et al. A phase II dose escalation trial of high dose fluconazole with and without flucytosine for AIDS associated cryptococcal meningitis [Abstr. No. 5]. In: Program and Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, D.C.: Foundation for Retrovirology and Human Health, 2006; pg. 65.
  100. Milefchik E, Leal M, Haubrich R, et al. A phase II dose escalation trial of high dose fluconazole with and without flucytosine for AIDS associated cryptococcal meningitis [Abstr. No. 5]. In: Program and Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, D.C.: Foundation for Retrovirology and Human Health, 2006; pg. 65.
  101. Miles SA, Lee K, Hutlin L, Zsebo KM, Mitsuyasu RT. Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias. Blood 78(12):3200-3208, 1991.
  102. Miles SA. The use of hematopoietic growth factors in HIV infection and AIDS-related malignancies. Cancer Investigation 9(2):229-238, 1991.
  103. Miles SA. Hematopoietic growth factors as adjuncts to antiretroviral therapy. AIDS Research and Human Retroviruses 8(6):1073-1080, 1992.
  104. Miles SA, Mitsuyasu RT, Moreno J, Baldwin G, Alton NK, Souza L, Glaspy JA. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood 77(10):2109-2117, 1991.
  105. Minkoff HL, Willoughby A, Mendez H, Moroso G, Holan S, Goedert JJ, Landesman SH. Serious infections during pregnancy among women with advanced human immunodeficiency virus infection. Am J Obstet Gynecol 1990;162:30-4.
  106. Minkoff HL, Henderson C, Mendez H, Gail MH, Holman S, Willougkby A, Goedett JJ, Rubinstein A, Stratton P, Walsh JH, et al. Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects. Am J Obstet Gynecol 1990;163:1598-604.
  107. Minkoff HL, McCalla S, Delke I, Stevens R, Salwen M, Feldman J. The relationship of cocaine use to syphilis and human immunodeficiency virus infections among inner city parturient women. Am J Obstet Gynecol 1990;163:521-6.
  108. Minkoff HL, Landesman SH. The case for routinely offering prenatal testing for human immunodeficiency virus. Am J Obstet Gynecol 1988;159:793-6.
  109. Minkoff IL, DeHovitz JA. Care of women infected with the human immunodeficiency virus. JAMA 1991;266:2253-8.
  110. Mofenson LM. Epidemiology and determinants of vertical HIV transmission. Seminars in Pediatric Infectious Diseases, Vol 5, 1994, pp 252-265.
  111. Monfardini S, Tirelli U, Vaccher E. Treatment of acquired immunodeficiency syndrome (AiDS)-related cancer. Cancer Treatment Reviews 20(2):149-172, 1994.
  112. Moore RD, Keruly JC, Chaisson RE. Neutropenia and bacterial infection in acquired immunodeficiency syndrome. Arch Int Med 155:1965-1970, 1994.
  113. Nachman RL, Silverstein R. Hypercoagulable states. Ann Intern Med 1993;119:819-827
  114. Narayan H, Cullimore J, Krarup K, Thurston H, Macvicar J, Bolia A. Experience with the cardial inferior vena cava fii-ter as prophylaxis against pulmonary embolism in pregnant women with extensive deep venous thrombosis. Br J Obstet Gynaecol 1992;99:637-640
  115. Newman SB. Treatmere of epidemic Kaposi's sarcoma (KS) with intralesional vinblastine injection (IL-VLB). Am Soc Clin Oncol, New Orleans 1988; Abst 19:5.
  116. Nilsson IM, Kullander S. Coagulation and fibrinolytic studies during pregnancy. Acta Obstet Gynecol Scand 1967; 46:273-285
  117. Northfelt DW, Dezube B, Miller B, Mamelok RD, DuMond CE, Henry D. Randomized comparative trial of doxil rs. adriamycin, bleomycin, and vincristine (ABV) in the treatment of severe AIDS-related Kaposi's sarcoma (AIDS-KS). Am Soc of Hematol, 37th Annual Meeting, Seattle, WA, December 1-5 1995. Abstract 1515, pg. 352a.
  118. Odajnyk C, Subar M, Dugan M, et al. Clinical features and correlation with immunopathology and molecular biology in a large group of patients with AIDS-associated small non-cleaved cell lymphoma (SNCL). ASH, San Francisco 1986 Abst 403:131 a.
  119. Pappas PG, Pottage JC, Powderly WG, et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1992; 116:847-853.
  120. PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. JAMA 1990;263:27532759
  121. Pitrak DL, Bak P, DeMarais P, et al. Depressed neutrophil superoxide production in HIV infection. J Infect Dis 167:1406-1410, 1993.
  122. Pluda JM, Mitsuya H, Yarchoan R. Hematologic effects of AIDS therapies. Hematology/Oncology Clinics of North America 5(2):229-248, 1991
  123. Polak JF, Wilkinson DL. Ultrasonographic diagnosis of symptomatic deep venous thrombosis in pregnancy. Am J Obstet Gynecol 1991;165:625-629
  124. Pottage JC Jr, Sha BE. Development of histoplasmosis in a human immunodeficiency virus-infected patient receiving fluconazole (letter). J Infect Dis 1991; 164:622-623.
  125. Powderly WG, Tuazon C, Cloud GA, et al. Serum and CSF cryptococcal antigen in management of cryptococcal meningitis in AIDS [Abstr. No. 6]. In: Program and Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, D.C.: Foundation for Retrovirology and Human Health, 2006; pg. 66.
  126. Powderly WG, Finkelstein DM, Feiriberg J, et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995; 332:700-5.
  127. Pridmore BR, Murray KH, McAllen PM. The management of anticoagulant therapy during and after pregnancy. Br J Obstet Gynaecol 1975;82:740-744
  128. Roilides E, Walsh TJ, Pizzo PA, Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. Journal of Infectious Diseases 163:579-583, 1991.
  129. Roilides E, Pizzo PA. Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts. Clin Infec Dis 15:508-524, 1992.
  130. Rutherford GW, Schwarcz SK, Letup GF, et al. The epidemiology of AIDS-related Kaposi's sarcoma in San Francisco. J Inf Dis 159:569-572, 1989.
  131. Ryder RW, Nga W, Hassig SE, et al. Perinatal transmission of the human immunodeficiency virus type I to infants of seropositive women in Zaire. N Engl J Med 1989;320:1637-1642.
  132. Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992; 326:83-89.
  133. Sasahara AA, Sharma GVRK, Barsamian EM, Schoolman M, Cella G. Pulmonary thromboembolism. Diagnosis and treatment. JAMA 1983;249:2945-2950
  134. Scadden DT. The use of GM-CSF in AIDS. Infection 20 Supp12:S103-S106, 1992.
  135. Scadden DT, Bering HA, Levine JD, et al. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alpha and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma. Journal of Clinical Oncology 9:802-808, 1991.
  136. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Larfars G, Nicol P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995;332:1661-1665
  137. Schuman P, Vazquez J, Sobel JD, et al. A randomized trial comparing fluconazole with placebo for prophylaxis of mucosal candidiasis in women with human immunodeficiency virus infection [Abstr. No. Tu.B.411] . In: Abstracts of the XI International Conference on AIDS, Vancouver, B.C.: XI International Conference on AIDS Society, 2006; pg. 236.
  138. Scott GB, Hutto C, Makuch RW, et al. Survival of children in perinatally acquired human immunodeficiency virus type I infection. N Engl J Med 1989;321:1791-1796.
  139. Selwyn PA, Schoenbaum EE, Davenny K, et al. Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA 1989;261:1289-1294.
  140. Sha BE, Benson CA, Pottage JC Jr, et al. HIV infection in women: a six year longitudinal, observational study. J Acquired Immune Def Synd Human Retrovirol 1995; 8:486-95.
  141. Shaul WL, Hall JG. Multiple congenital anomalies associated with oral anticoagulants. Am J Obstet Gynecol 1977; 127:191-198
  142. Shiramizu B, Hemdier B, Meeker T, Kaplan L, McCrrath M. Molecular and immunophenotypic characterization of AIDS-associated, Epstein-Bart virus-negative, polyclonal lymphoma J Clin OncoI 1992; 10:383-389.
  143. Smith DE, Midgley J, Allan M, Connolly GM, Gazzard BG. Itraconazole versus ketoconazole in the treatment of oral and esophageal candidosis in patients infected with HIV. AIDS 1991; 5:1367-1371.
  144. Sperling R, Stratton P. Treatment options for human immunodeficiency virus-infected pregnancy women. Obstet Gynecol 1992;79:443.
  145. Stevenson RE, Burton OM, Ferlauto GJ, Taylor HA. Hazards of oral anticoagulants during pregnancy. JAMA 1980; 243:1549-1551
  146. Sturridge F, de Swiet M, Letsky E. The use of low molecular weight heparin for thromboprophylaxis in pregnancy. Br J Ohstet Gynaecol 1994; 101:69-71
  147. Subar M, Neri A, Inghirami G, Kaowles DM, Dalla-Favera R. Frequent c-myc oncogene activation and infrequent presence of Epstein-Bart virus genome in AIDS-associated lymphoma Blood 1988; 72:667-671.
  148. Sugar AM, Saunders C. Oral fluconazole as suppressire therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85:481-489.
  149. Tappero JW, Berger TG, Kaplan LD, et al: Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a phase II thai. JAIDS 4:839-846, 1991.
  150. The European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994;343:1464-67.
  151. Todd ME, Thompson JH Jr, Bowie EJW, Owen CA Jr. Changes in blood coagulation during pregnancy. Mayo Clin Proc 1965;40:370-383
  152. Tuomala R. Human immunodeficiency virus education and screening of prenatal patients. Obstet Gynecol Clinics NAmer 1990;17:571-83.
  153. Villar P, et al. Cesarean section to reduce perinatal transmission of human immunodeficiency virus: a meta-analysis. Curr Clinical Trials 1993;74:1-15.
  154. Villasanta U. Thromboembolic disease in pregnancy. Am J Obstet Gynecol 1965;93:142-160
  155. Vogel J, Hinrichs SH, Reynolds RK, et al. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 335:606-611, 1988.
  156. Volberding PA, Abrams DI, Conant M, Kaslow K, Vranizan K, Ziegler J. Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Int Med 103:335-338, 1985.
  157. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or un-fractionated heparin. N Engl J Med 1995;332:1330-1335
  158. Weinmann EE, Salzman EW. Deep-vein thrombosis. N Engl J Med 1994;331:1630-1641
  159. Wellstein A, Zugmaier G, and Califano III JA et al. Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate. J Nat Can Inst 83:716-720, 1991.
  160. Wessler S, Gitel SN. Heparin: new concepts relevant to clinical use. Blood 1979;53:525-544
  161. Wessler S, Gitel SN. Warlatin. From bedside to bench. N Engl J Meal 1984;311:645-652
  162. Wessler S. Medical management of venous thrombosis. Annu Rev Med 1976;27:313-319
  163. Wheat LJ, Connolly-Stringfield P, Blair R, Connolly K, Garringer T, Katz BP. Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. Ann Intern Med 1991; 115:936-941.
  164. Wheat LJ, Hafner R, Wulfson M, et al. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1993; 118:610-616.
  165. Wheat LJ, Connolly-Stringfield P, Kohler RB, Frame PT, Gupta MR. Histoplasma capsulatum polysaccharide antigen detection in diagnosis and management of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med 1989; 87:396-400.
  166. Wheat LJ. Histoplasmosis in AIDS. AIDS Clin Care 1992; 4:14.
  167. Whitfield LR, Lele AS, Levy G. Effect of pregnancy on the relationship between concentration and anticoagulant action of heparin. Clin Pharm Ther 1983 ;34:23-28
  168. Ziegler JL, et al. Non-hodgkin's lymphoma in 90 homosexual men: relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984; 311:565-570.

Additional References